Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1653 1657 1759
This examiner grants 58% of resolved cases
Candice Lee Swift is an examiner in Tech Center 1700, working in Art Unit 1651. She has 127 resolved cases with an allowance rate of 57.5%. This figure shows that a majority of cases reach allowance. The data also highlights a substantial interview lift of 36.0%, which is a key factor for practitioners to consider when planning their strategy.
The median days to allowance is 1176. This pendency data helps applicants understand the typical duration of prosecution in Art Unit 1651. The 36.0% interview lift suggests that verbal communication is particularly effective for this examiner. With 127 resolved cases, the 57.5% allowance rate provides a solid baseline for expectations in Tech Center 1700. The 1176-day median is a critical metric for managing client timelines and expectations throughout the examination process.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18685498 | NOVEL ACETOHYDROXY ACID SYNTHASE SUBUNIT VARIANT AND METHOD FOR PRODUCING L-VALINE USING SAME | Final Rejection | CJ CHEILJEDANG CORPORATION |
| 17617285 | SYSTEMS COMPRISING SUBSTRATES AND METHODS OF USING THE SAME FOR DETECTION OF PANCREATIC CANCERS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18548719 | Method of Evaluating the Biofilm Detachment Efficacy of Compositions | Final Rejection | The Ohio State University |
| 18686227 | METHOD FOR PRODUCING PROTEIN MATERIAL WITHOUT USING ORGANIC SOLVENT | Final Rejection | TOPPAN HOLDINGS INC. |
| 18274757 | ENGINEERED BACTERIA AND METHODS OF PRODUCING TRIACYLGLYCERIDES | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18570566 | POLYHYDROXYALKANOATES AND METHODS OF MAKING THEREOF | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18255203 | ENGINEERED PROBIOTIC COMPOSITIONS AND USES THEREOF | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18690479 | Modified Bont/A for Use in the Treatment of a Disorder Affecting an Eyelid Muscle of a Subject | Non-Final OA | Ipsen Biopharm Limited |
| 18690378 | Modified Bont/A for Use in the Treatment of Cervical Dystonia | Non-Final OA | Ipsen Biopharm Limited |
| 18561144 | NOVEL TECHNOLOGY TO ENABLE SUCROSE UTILIZATION IN STRAINS FOR BIOSYNTHETIC PRODUCTION | Non-Final OA | DSM IP Assets B.V. |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | Final Rejection | DSM IP ASSETS B.V. |
| 18393145 | Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside | Final Rejection | China Agricultural University |
| 18688433 | INCREASING GROWTH OF A CO2 FIXING THERMOPHILE BACTERIUM | Non-Final OA | DANMARKS TEKNISKE UNIVERSITET |
| 18625942 | Conversion of lignin to muconic acid and methods therefor | Non-Final OA | UT-Battelle, LLC |
| 17799051 | RECOMBINANT SILK SOLIDS AND FILMS | Final Rejection | BOLT THREADS, INC. |
| 18712051 | THERMOSTABLE POLYMERASE VARIANTS | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18721629 | N-terminal and/or C-terminal Cleaved Soluble PH20 Polypeptide and Use Thereof | Non-Final OA | ALTEOGEN, Inc. |
| 18001637 | DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPEUTIC | Non-Final OA | MEDIMMUNE, LLC |
| 18690504 | OVER EXPRESSION OF FOLDASES AND CHAPERONES IMPROVES PROTEIN PRODUCTION | Final Rejection | DUPONT NUTRITION BIOSCIENCES APS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy